AB Science
AB | PA
Overview
Corporate Details
- ISIN(s):
- FR0010557264 (+1 more)
- LEI:
- 969500U43TVR8CCVBJ97
- Country:
- France
- Address:
- 3 AVENUE GEORGE V, 75008 PARIS
- Website:
- https://www.ab-science.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing innovative drugs for high unmet medical needs. The Company is based in Paris and has been listed on Euronext since 2010 (compartment B, Paris, France). AB Science has over 100 employees, mostly dedicated to R&D activities. AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939, a new generation microtubule destabilizer. In human medicine, AB Science has a unique indication portfolio with multiple late-stage programs including blockbuster potential and orphan diseases. Masitinib has already generated positive phase 2B/3 results in Amyotrophic Lateral Sclerosis, Indolent Systemic Mastocytosis, Severe Asthma, Progressive Forms of Multiple Sclerosis, First Line Pancreatic Cancer with Pain, Alzheimer’s Disease and Metastatic Castrate-Resistant Prostate Cancer.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-04 07:58 |
Prospectus
AB Science annonce le succès d’un placement privé d’environ 2,55 millions d’eur…
|
French | 332.3 KB | |
| 2025-08-04 07:58 |
Prospectus
AB Science announces the successful completion of a 2.55 million euros private …
|
English | 323.2 KB | |
| 2025-07-24 07:56 |
Regulatory News Service
AB Science has received approval from several European countries to initiate th…
|
English | 297.9 KB | |
| 2025-07-24 07:56 |
Regulatory News Service
AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’é…
|
French | 273.3 KB | |
| 2025-06-23 08:03 |
Regulatory News Service
AB Science - New peer-reviewed data provide strong evidence supporting masitini…
|
English | 307.5 KB | |
| 2025-06-23 08:03 |
Regulatory News Service
AB Science - De nouvelles données évaluées par des pairs apportent des preuves …
|
French | 290.6 KB | |
| 2025-06-12 07:59 |
Regulatory News Service
AB Science annonce la délivrance d’un brevet canadien protégeant la composition…
|
French | 197.9 KB | |
| 2025-06-12 07:59 |
Regulatory News Service
AB Science announces issuance of a Canadian patent protecting the composition o…
|
English | 221.7 KB | |
| 2025-06-09 08:00 |
Regulatory News Service
AB Science annonce l’approbation par l’EMA de la prolongation de la durée de co…
|
French | 164.5 KB | |
| 2025-06-09 08:00 |
Regulatory News Service
AB Science announces EMA approval of Masivet shelf-life extension to 4 years
|
English | 194.6 KB | |
| 2025-05-23 07:52 |
Capital/Financing Update
AB Science announces the settlement delivery of its latest capital increase for…
|
English | 199.0 KB | |
| 2025-05-23 07:52 |
Capital/Financing Update
AB Science :
|
French | 229.0 KB | |
| 2025-05-20 07:49 |
Capital/Financing Update
AB Science annonce le succès d'un placement privé de 1,8 millions d'euros
|
French | 282.8 KB | |
| 2025-05-20 07:49 |
Capital/Financing Update
AB Science announces the successful completion of a EUR 1.8 million private pla…
|
English | 269.4 KB | |
| 2025-05-19 07:51 |
Regulatory News Service
AB Science receives Chinese patent protecting masitinib in the treatment of Cov…
|
English | 229.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC | |
|
Adocia | France | ADOC |